© 2020 MJH Life Sciences and Medical Economics. All rights reserved.
© 2020 MJH Life Sciences™ and Medical Economics. All rights reserved.
Study suggests all adults age 18 and older should be screened for HCV.
Shorter treatment could significantly reduce costs of therapy.
Effective direct-acting antivirals are available for teens.
Strong evidence supports removal of restrictions to direct-acting antiviral therapy based on recent drug use.